Primary Outcome
Mortality within 90 days occurred in 236 of 14 156 patients (1.67%) in the aspirin group and in 142 of 9302 patients (1.53%) in the enoxaparin group. The difference between groups was not statistically significant (estimated difference, 0.04%; 95% CI, −0.38% to 0.46%) (